ICON Dirección
Dirección controles de criterios 4/4
El CEO de ICON's es Steve Cutler , nombrado en Mar 2017, tiene una permanencia de 7.25 años. compensación anual total es $7.24M, compuesta por 16.4% salario y 83.6% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.045% de las acciones de la empresa, por valor de $11.74M. La antigüedad media del equipo directivo y de la junta directiva es de 12.3 años y 7.2 años, respectivamente.
Información clave
Steve Cutler
Chief Executive Officer (CEO)
US$7.2m
Compensación total
| Porcentaje del salario del CEO | 16.4% |
| Permanencia del CEO | 7.5yrs |
| Participación del CEO | 0.04% |
| Permanencia media de la dirección | 8.2yrs |
| Promedio de permanencia en la Junta Directiva | 7.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors
Sep 25
Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Sep 09We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt
Aug 25An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued
Aug 10ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)
Jul 13Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)
Jun 14Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching
May 30ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet
May 14ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 28What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?
Apr 21ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price
Apr 05ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump
Mar 05With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Feb 07ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
Feb 01These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Jan 23Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jan 08What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E
Dec 24A Look At The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
Dec 09With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Nov 08Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching
Oct 09Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Sep 23Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
Sep 05Does ICON (NASDAQ:ICLR) Deserve A Spot On Your Watchlist?
Aug 03Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jun 30Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Jun 12Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
May 23Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Mar 29Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Mar 11Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 28%?
Feb 21Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching
Dec 28These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Dec 10Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 26% Discount?
Nov 22Icon selected by BARDA to conduct anthrax vaccine clinical trial
Oct 06Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?
Sep 15ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly
Aug 26Baron Funds - ICON Plc: Positioned For An Extended Period Of Revenue And Earnings Growth
Aug 11Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 41%?
Aug 01Icon Q2 2022 Earnings Preview
Jul 26ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet
May 11Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$714m |
| Mar 31 2024 | n/a | n/a | US$683m |
| Dec 31 2023 | US$7m | US$1m | US$612m |
| Sep 30 2023 | n/a | n/a | US$513m |
| Jun 30 2023 | n/a | n/a | US$510m |
| Mar 31 2023 | n/a | n/a | US$510m |
| Dec 31 2022 | US$10m | US$1m | US$505m |
| Sep 30 2022 | n/a | n/a | US$464m |
| Jun 30 2022 | n/a | n/a | US$210m |
| Mar 31 2022 | n/a | n/a | US$168m |
| Dec 31 2021 | US$10m | US$1m | US$153m |
| Sep 30 2021 | n/a | n/a | US$178m |
| Jun 30 2021 | n/a | n/a | US$364m |
| Mar 31 2021 | n/a | n/a | US$338m |
| Dec 31 2020 | US$8m | US$1m | US$328m |
| Sep 30 2020 | n/a | n/a | US$322m |
| Jun 30 2020 | n/a | n/a | US$324m |
| Mar 31 2020 | n/a | n/a | US$368m |
| Dec 31 2019 | US$8m | US$1m | US$369m |
| Sep 30 2019 | n/a | n/a | US$362m |
| Jun 30 2019 | n/a | n/a | US$353m |
| Mar 31 2019 | n/a | n/a | US$333m |
| Dec 31 2018 | US$8m | US$1m | US$323m |
| Sep 30 2018 | n/a | n/a | US$306m |
| Jun 30 2018 | n/a | n/a | US$295m |
| Mar 31 2018 | n/a | n/a | US$288m |
| Dec 31 2017 | US$7m | US$1m | US$281m |
Compensación vs. Mercado: La compensación total de Steve($USD7.24M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD13.53M).
Compensación vs. Ingresos: La compensación de Steve ha sido consistente con los resultados de la empresa en el último año.
CEO
Steve Cutler (64 yo)
7.5yrs
Permanencia
US$7,244,000
Compensación
Dr. Steven A. Cutler, also known as Steve, Ph D., MBA, serves as Chairman of Association of Clinical Research Organizations since January 01, 2021. He has been the Chief Executive Officer of ICON Public Li...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 7.5yrs | US$7.24m | 0.045% $ 10.6m | |
| Founder & Independent Non-Executive Director | no data | US$290.00k | 0.54% $ 128.5m | |
| Chief Financial Officer | less than a year | sin datos | sin datos | |
| Senior Vice President of Corporate & Commercial Finance | no data | sin datos | sin datos | |
| Chief Information Officer | no data | sin datos | sin datos | |
| Chief Administrative Officer | 14.8yrs | sin datos | 0.0096% $ 2.3m | |
| Director of Corporate Communications | no data | sin datos | sin datos | |
| Vice President of Marketing | no data | sin datos | sin datos | |
| Chief Human Resources Officer | 8.2yrs | sin datos | sin datos | |
| President of Corporate Investments & Partnerships | 1.8yrs | sin datos | sin datos | |
| Senior Vice President of Global Clinical Pharmacology | 15.4yrs | sin datos | sin datos | |
| Senior Vice President of Drug Development Services - CNS | 17.7yrs | sin datos | sin datos |
8.2yrs
Permanencia media
53.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de ICLR es experimentado (12.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 8.8yrs | US$7.24m | 0.045% $ 10.6m | |
| Founder & Independent Non-Executive Director | 14.7yrs | US$290.00k | 0.54% $ 128.5m | |
| Independent Director | 3.2yrs | US$303.00k | 0.0054% $ 1.3m | |
| Independent Non-Executive Director | 6.9yrs | US$323.00k | 0.0026% $ 605.5k | |
| Independent Non-Executive Chairman of the Board | 12.9yrs | US$656.00k | 0.023% $ 5.5m | |
| Lead Independent Director | 7.9yrs | US$359.00k | 0.0026% $ 605.5k | |
| Non-Executive Director | less than a year | sin datos | sin datos | |
| Independent Non-Executive Director | 5.2yrs | US$315.00k | 0.0023% $ 551.1k |
7.4yrs
Permanencia media
64.5yo
Promedio de edad
Junta con experiencia: La junta directiva de ICLR se considera experimentada (7.2 años de antigüedad promedio).